Jiangsu Mole Bioscience Co., Ltd. ("Mole Bioscience") is a high-tech enterprise that is committed to the R&D, production and
sales of molecular diagnostic reagents by leveraging the resources of Zhejiang University.Powered by the industrialization
platform, Mole Bioscience boasts multiplex fluorescence quantitative PCR, high-throughput sequencing, and antigen/antibody
detection technologies, and provides more than 200 products among which 24 products are already registered with CFDA.
The company's in vitro diagnostic reagents have been widely applied in more than 200 provincial and municipal hospitals,
CDC and Independent Clinical Laboratories(ICH) nationwide for the detection of infectious and genetic diseases, as well as
gene testing before individual therapy of tumor patients.